FindTrial
Sign In

Assessment and Evaluation of Phenotype-Driven Approach for Early Detection of Cancer Predisposition Syndromes in Pediatric Cancer Patients

Assessment and yield of phenotype driven approach for detection of cancer predisposition syndrome in children with cancer - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087529
Enrollment
350
Registered
2025-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Children with proven cancer diagnosis being treated or having received treatment in the last 6 months either upfront or at relapse, or patients with rare tumours on follow up (first diagnosis of cancer at less than or equals to 15 years of age)

Exclusion criteria

Exclusion criteria: Those who are not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
To determine efficacy of phenotypic driven approach to diagnose CPS in children diagnosed with cancer.Timepoint: At baseline—

Secondary

MeasureTime frame
To correlate concordance of phenotypic driven approach with McGill PediatricOnco Genetic Guidelines (MIPOGG) application.Timepoint: Survival at the end of the study—

Countries

India

Contacts

Public ContactDr Badira Parambil

Tata Memorial Hospital

mondalarghya82@gmail.com8001638651

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026